500660:BOM
GlaxoSmithKline Pharmaceuticals Ltd
₹2,567.25
arrow_upward
+1.75%(+44.25) 1D
Oct 16, 3:30:00 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 500660...
Open
₹2,527.25
High
₹2,572.40
Low
₹2,527.25
Mkt. cap
434.57B
Avg. vol.
5.03K
Volume
2.37K
Dividend
2.22%
Quarterly dividend
₹14.25
Ex-dividend date
May 29, 2026
P/E ratio
40.72
52-wk high
₹3,121.10
52-wk low
₹2,088.00
EPS
₹63.05
Shares outstanding
169.41M
No. of employees
3K
Open
₹2,527.25
High
₹2,572.40
Low
₹2,527.25
Mkt. cap
434.57B
Avg. vol.
5.03K
Volume
2.37K
Dividend
2.22%
Quarterly dividend
₹14.25
Ex-dividend date
May 29, 2026
P/E ratio
40.72
52-wk high
₹3,121.10
52-wk low
₹2,088.00
EPS
₹63.05
Shares outstanding
169.41M
No. of employees
3K
News stories
From web sources and news partners
marketscreener.com
·
20 minutes ago
S&P 500 Correction Risk Grows as Index Rally Lacks Broad Participation
Quartz
·
59 minutes ago
S&P 500 futures rise as index heads for weekly loss
Benzinga
·
30 minutes ago
S&P 500 Could Hit 9,000 Without Iran War: Why Kobeissi Letter Sees a ‘Historic Opportunity’ for a ‘Violen
Yahoo Finance
·
2 hours ago
3 S&P 500 Stocks We Steer Clear Of
Profile
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia
About GlaxoSmithKline Pharmaceuticals Ltd
CEO-
Employees3.1K
FoundedNov 13, 1924
Headquarters-
SectorPharmaceutical industry
Websiteindia-pharma.gsk.com